Literature DB >> 29753649

Comparison of subacute and chronic scar tissues after complete spinal cord transection.

Xing Li1, Bin Yang1, Zhifeng Xiao1, Yannan Zhao1, Sufang Han1, Yanyun Yin1, Bing Chen1, Jianwu Dai2.   

Abstract

Traditional views consider scar tissue formed in the lesion epicenter after severe spinal cord injury (SCI) as both a physical barrier and chemical impediment for axonal regeneration. Recently, a controversial opinion suggested that astrocyte scar formation aids rather than prevents axonal regeneration in the CNS. Here, following complete transection of the thoracic spinal cord (T8) in rats, we found that scar tissue showed greater growth factor expression at 2 weeks than 8 weeks post-SCI. Further, tandem mass tag (TMT)-based quantitative proteomic analysis revealed that the components of scar tissue formed in the subacute phase are quite different from that formed in the chronic phase. We also found significantly increased axonal regrowth of sensory axons into the lesion center after chronically formed scar tissue was removed. This indicates that scar tissue formed at the chronic phase actually inhibits axonal regeneration, and that chronic removal of scar tissue may have clinical significance and benefit for SCI repair. Taken together, our study suggests that the features and roles of subacute and chronic scar tissues formed post-SCI is different and scar tissue-targeted strategies for spinal cord regeneration cannot be generalized.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axon regeneration; Complete spinal cord transection; Neuronal relay; Quantitative proteomics; Scar tissue

Mesh:

Substances:

Year:  2018        PMID: 29753649     DOI: 10.1016/j.expneurol.2018.05.008

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

Review 1.  Astrocyte polarization in glaucoma: a new opportunity.

Authors:  Yi-Xin Liu; Hao Sun; Wen-Yi Guo
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

Review 2.  Moving beyond the glial scar for spinal cord repair.

Authors:  Elizabeth J Bradbury; Emily R Burnside
Journal:  Nat Commun       Date:  2019-08-28       Impact factor: 14.919

3.  Dissecting the Dual Role of the Glial Scar and Scar-Forming Astrocytes in Spinal Cord Injury.

Authors:  Tuo Yang; YuJuan Dai; Gang Chen; ShuSen Cui
Journal:  Front Cell Neurosci       Date:  2020-04-03       Impact factor: 5.505

Review 4.  Reactive Astrogliosis: Implications in Spinal Cord Injury Progression and Therapy.

Authors:  Xinyu Li; Meng Li; Lige Tian; Jianan Chen; Ronghan Liu; Bin Ning
Journal:  Oxid Med Cell Longev       Date:  2020-08-19       Impact factor: 6.543

Review 5.  Dynamic Diversity of Glial Response Among Species in Spinal Cord Injury.

Authors:  Jean-Christophe Perez; Yannick N Gerber; Florence E Perrin
Journal:  Front Aging Neurosci       Date:  2021-11-26       Impact factor: 5.750

6.  Effect of Velocity and Contact Stress Area on the Dynamic Behavior of the Spinal Cord Under Different Testing Conditions.

Authors:  Chen Jin; Rui Zhu; Meng-Lei Xu; Liang-Dong Zheng; Hui-Zi Zeng; Ning Xie; Li-Ming Cheng
Journal:  Front Bioeng Biotechnol       Date:  2022-03-04

Review 7.  The immune microenvironment and tissue engineering strategies for spinal cord regeneration.

Authors:  Yuan Feng; Yong Peng; Jing Jie; Yumin Yang; Pengxiang Yang
Journal:  Front Cell Neurosci       Date:  2022-08-04       Impact factor: 6.147

8.  NPC transplantation rescues sci-driven cAMP/EPAC2 alterations, leading to neuroprotection and microglial modulation.

Authors:  Beatriz Martínez-Rojas; Esther Giraldo; Rubén Grillo-Risco; Marta R Hidalgo; Eric López-Mocholi; Ana Alastrue-Agudo; Francisco García-García; Victoria Moreno-Manzano
Journal:  Cell Mol Life Sci       Date:  2022-07-29       Impact factor: 9.207

Review 9.  Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease.

Authors:  Paulina Troncoso-Escudero; Alejandra Parra; Melissa Nassif; Rene L Vidal
Journal:  Front Neurol       Date:  2018-10-15       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.